New Gene Editing Technique Helps Immune System Fight Common Gastrointestinal Cancer, Study Finds — The Lancet Oncology

Researchers at the University of Minnesota have completed the first human clinical trial of the CRISPR/Cas9 gene-editing technique, which may help the immune system combat common forms of gastrointestinal (GI) cancer. Results recently published in The Lancet Oncology show promising signs of the treatment’s safety and potential effectiveness. In the study, scientists used CRISPR/Cas9 gene-editing…